Perceptions and Intention to Get Vaccinated against Mpox among the LGBTIQ+ Community during the 2022 Outbreak : A Cross-Sectional Study in Peru
Vaccination against mpox can control the outbreak by targeting high-risk groups such as the LGBTIQ+ community. The aim of the study was to evaluate the perceptions and intentions to get vaccinated against mpox among the LGBTIQ+ community in Peru. We conducted a cross-sectional study from 1 November 2022 to 17 January 2023 in Peru. We included individuals over 18 years old, belonging to the LGBTIQ+ community, and residing in the departments of Lima and Callao. To evaluate the factors associated with the intention to be vaccinated, we used Poisson regression with robust variance to create a multivariate model. The study comprised 373 individuals who self-identified as members of the LGBTIQ+ community. The participants had a mean age of 31 years (SD ± 9), with 85.0% males and 75.3% reporting to be homosexual men. The majority (88.5%) expressed their intention to receive the vaccine against mpox. Believing that the vaccine is safe was associated with a higher intention to be vaccinated (aPR: 1.24; 95% CI: 1.02 to 1.50; p = 0.028). Our study population showed a high level of mpox vaccination intent. Educational campaigns reinforcing the concept of vaccine safety should be conducted to increase the intention and possibly the vaccination rate in the LGBTIQ+ community.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
---|---|
Enthalten in: |
Vaccines - 11(2023), 5 vom: 21. Mai |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Araoz-Salinas, Julieta M [VerfasserIn] |
---|
Links: |
---|
Themen: |
Bisexuality |
---|
Anmerkungen: |
Date Revised 29.05.2023 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3390/vaccines11051008 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM357453395 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM357453395 | ||
003 | DE-627 | ||
005 | 20231226072625.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/vaccines11051008 |2 doi | |
028 | 5 | 2 | |a pubmed24n1191.xml |
035 | |a (DE-627)NLM357453395 | ||
035 | |a (NLM)37243112 | ||
035 | |a (PII)1008 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Araoz-Salinas, Julieta M |e verfasserin |4 aut | |
245 | 1 | 0 | |a Perceptions and Intention to Get Vaccinated against Mpox among the LGBTIQ+ Community during the 2022 Outbreak |b A Cross-Sectional Study in Peru |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 29.05.2023 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Vaccination against mpox can control the outbreak by targeting high-risk groups such as the LGBTIQ+ community. The aim of the study was to evaluate the perceptions and intentions to get vaccinated against mpox among the LGBTIQ+ community in Peru. We conducted a cross-sectional study from 1 November 2022 to 17 January 2023 in Peru. We included individuals over 18 years old, belonging to the LGBTIQ+ community, and residing in the departments of Lima and Callao. To evaluate the factors associated with the intention to be vaccinated, we used Poisson regression with robust variance to create a multivariate model. The study comprised 373 individuals who self-identified as members of the LGBTIQ+ community. The participants had a mean age of 31 years (SD ± 9), with 85.0% males and 75.3% reporting to be homosexual men. The majority (88.5%) expressed their intention to receive the vaccine against mpox. Believing that the vaccine is safe was associated with a higher intention to be vaccinated (aPR: 1.24; 95% CI: 1.02 to 1.50; p = 0.028). Our study population showed a high level of mpox vaccination intent. Educational campaigns reinforcing the concept of vaccine safety should be conducted to increase the intention and possibly the vaccination rate in the LGBTIQ+ community | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Peru | |
650 | 4 | |a bisexuality | |
650 | 4 | |a homosexuality | |
650 | 4 | |a intention | |
650 | 4 | |a monkeypox | |
650 | 4 | |a perception | |
650 | 4 | |a public health | |
650 | 4 | |a vaccination | |
700 | 1 | |a Ortiz-Saavedra, Brando |e verfasserin |4 aut | |
700 | 1 | |a Ponce-Rosas, Linda |e verfasserin |4 aut | |
700 | 1 | |a Soriano-Moreno, David R |e verfasserin |4 aut | |
700 | 1 | |a Soriano-Moreno, Anderson N |e verfasserin |4 aut | |
700 | 1 | |a Alave, Jorge |e verfasserin |4 aut | |
700 | 1 | |a Gonzales-Zamora, Jose A |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Vaccines |d 2012 |g 11(2023), 5 vom: 21. Mai |w (DE-627)NLM239212347 |x 2076-393X |7 nnns |
773 | 1 | 8 | |g volume:11 |g year:2023 |g number:5 |g day:21 |g month:05 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/vaccines11051008 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 11 |j 2023 |e 5 |b 21 |c 05 |